Reported data shows an increase in γ-hydroxybutyrate-associated deaths in London. Data suggests deaths are disproportionally high compared to use. Evidence is reported to suggest a possible link with concomitant rise in chemsex. Gamma-hydroxybutyrate-associated deaths are likely to be under-reported.